Zobrazeno 1 - 10
of 8 981
pro vyhledávání: '"Interleukin-4 receptor"'
Autor:
Williams, Demond1 (AUTHOR) demond.williams@vanderbilt.edu, Hargrove-Wiley, Ebony1 (AUTHOR) ebony.l.hargrove-wiley@vanderbilt.edu, Bindeman, Wendy1 (AUTHOR) wendy.e.bindeman@vanderbilt.edu, Valent, Daniel1 (AUTHOR) daniel.valent@vanderbilt.edu, Miranda, Adam X.1 (AUTHOR) adam.x.miranda@vanderbilt.edu, Beckstead, Jacob2 (AUTHOR) jacob.a.beckstead@vanderbilt.edu, Fingleton, Barbara1 (AUTHOR) barbara.fingleton@vanderbilt.edu
Publikováno v:
International Journal of Molecular Sciences. May2024, Vol. 25 Issue 9, p4647. 16p.
Autor:
Diaba-Nuhoho P; Department of Chemical Pathology, University of Ghana, Korle-Bu, Accra, Ghana. diabanuh@uni-muenster.de.; Department of Paediatric and Adolescent Medicine, Paediatric Haematology and Oncology, University Hospital Münster, 48149, Münster, Germany. diabanuh@uni-muenster.de.
Publikováno v:
BMC research notes [BMC Res Notes] 2024 Oct 31; Vol. 17 (1), pp. 328. Date of Electronic Publication: 2024 Oct 31.
Autor:
Chan R; Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, UK., Stewart K; Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, UK., Kuo CR; Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, UK., Lipworth B; Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, UK.
Publikováno v:
Allergy [Allergy] 2024 Oct; Vol. 79 (10), pp. 2873-2875. Date of Electronic Publication: 2024 Aug 16.
Autor:
Edwards DW; Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA., Kroepfl GM; Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA., Jackson JM; Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA., Chen S; Nationwide Children's Hospital, Columbus, OH, 43205, USA., Hudson-Price L; Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA., Srinivasa G; Datma, Beaverton, OR, 97005, USA., Kannan K; Datma, Beaverton, OR, 97005, USA., Liu Q; Department of Epidemiology and Biostatistics, University of Texas Health San Antonio, San Antonio, TX, 78229, USA., Michalek JE; Department of Epidemiology and Biostatistics, University of Texas Health San Antonio, San Antonio, TX, 78229, USA., Keller C; Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA. charles@cc-tdi.org.
Publikováno v:
Transgenic research [Transgenic Res] 2024 Aug; Vol. 33 (4), pp. 229-241. Date of Electronic Publication: 2024 Jun 08.
Autor:
Chen CC; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass. Electronic address: cchen32@bwh.harvard.edu., Buchheit KM; Department of Medicine, Harvard Medical School, and the Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass., Lee PY; Division of Immunology, Boston Children's Hospital, Boston, Mass., Brodeur KE; Division of Immunology, Boston Children's Hospital, Boston, Mass., Sohail A; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass., Cho L; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass., Baloh CH; Department of Medicine, Harvard Medical School, and the Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass., Balestrieri B; Department of Medicine, Harvard Medical School, and the Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass., Derakhshan T; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass., Feng C; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass., Boyce JA; Department of Medicine, Harvard Medical School, and the Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass., Dwyer DF; Department of Medicine, Harvard Medical School, and the Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass., Laidlaw TM; Department of Medicine, Harvard Medical School, and the Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Aug; Vol. 154 (2), pp. 458-467.e3. Date of Electronic Publication: 2024 May 03.
Autor:
McCann MR; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Kosloski MP; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Xu C; Sanofi, Bridgewater, New Jersey, USA., Davis JD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Kamal MA; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Aug; Vol. 17 (8), pp. e13899.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wu DH; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, United States.; Medical Scientist Training Program, Case Western Reserve University, Cleveland, Ohio, United States., Senyo SE; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, United States.
Publikováno v:
American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2024 May 01; Vol. 326 (5), pp. H1177-H1179. Date of Electronic Publication: 2024 Mar 22.
Autor:
Demond Williams, Ebony Hargrove-Wiley, Wendy Bindeman, Daniel Valent, Adam X. Miranda, Jacob Beckstead, Barbara Fingleton
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 9, p 4647 (2024)
Interleukin-4 (IL4) is a Th2 cytokine that can signal through two different receptors, one of which—the type II receptor—is overexpressed by various cancer cells. Previously, we have shown that type II IL4 receptor signaling increases proliferati
Externí odkaz:
https://doaj.org/article/ea92f0e459284ccab528a39ae97525c9
Autor:
Permpoon U; Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Cell & Matrix Research Institute, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Division of Biomedical Sciences, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand., Khan F; Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Cell & Matrix Research Institute, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Division of Biomedical Sciences, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea., Vadevoo SMP; Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Cell & Matrix Research Institute, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Division of Biomedical Sciences, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea., Gurung S; Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Cell & Matrix Research Institute, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Division of Biomedical Sciences, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea., Gunassekaran GR; Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Cell & Matrix Research Institute, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea., Kim MJ; Cell & Matrix Research Institute, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Division of Biomedical Sciences, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Department of Pharmacology, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea., Kim SH; Cell & Matrix Research Institute, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Division of Biomedical Sciences, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Department of Pharmacology, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea., Thuwajit P; Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand., Lee B; Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Cell & Matrix Research Institute, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.; Division of Biomedical Sciences, School of Medicine, Kyungpook National University, 680 Gukchaebosangro, Junggu, Daegu 41944, Republic of Korea.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2020 Nov 02; Vol. 17 (11), pp. 4077-4088. Date of Electronic Publication: 2020 Oct 22.